Champions Oncology Company
Champions Oncology develops advanced technology solutions and services for personalizing the development and use of oncology drugs.
(INV)%20.jpg)
Estimated Revenue:
$1M to $10M
Funding Status:
IPO
Industry:
End-to-End Drug Development
Investors Number:
4.0
Last Funding Date:
2015-03-12
Number Of Exists:
Post-IPO Equity
Technology:
Cancer
Founded Date:
1985-01-01
Investor Type:
Company
Headquarters:
Hackensack, New Jersey, United States
Total Funding:
36800000.0
Last Funding Type:
Post-IPO Equity
Employee Number:
51-100
Investment Stage:
N/A